Growth Hormone

Tesamorelin is a GHRH analogue that reduces visceral adipose tissue in clinical studies. Learn everything about its mechanism of action and research results.

CJC-1295 is a GHRH analogue with extended half-life for increased GH secretion. Everything about its effects, combination with ipamorelin and research status.

Ipamorelin is a selective growth hormone secretagogue with a high safety profile. Learn about its mechanism, combination with CJC-1295 and research results.

AOD-9604 is a modified fragment of human growth hormone with fat-burning properties but no IGF-1 stimulation. Learn about the research, clinical trials and findings.

GHRP-6 is one of the first synthetic growth hormone releasing peptides. Learn about the ghrelin-mimetic mechanism, GH pulse induction and research status.

Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). Learn about physiological GH stimulation, clinical studies on aging and research results.

GHRP-2 is a second-generation synthetic growth hormone secretagogue with more potent GH release compared to GHRP-6. Learn about the mechanism, comparison and research findings.

Hexarelin is the most potent synthetic growth hormone secretagogue in the GHRP family with additional cardioprotective properties. Learn about the research and effects.

Mod GRF 1-29 (CJC-1295 without DAC) is a stabilized GHRH analogue for natural pulsatile GH release. Learn about the difference to CJC-1295 with DAC and research findings.

HGH Fragment 176-191 is the lipolytic C-terminal region of human growth hormone without anabolic effects. Learn about the research on fat metabolism and weight management.

IGF-1 LR3 is a modified IGF-1 analogue with a longer half-life and stronger receptor affinity. Learn about anabolic effects, muscle research and scientific findings.